Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury
Farin Amersi, … , Ronald W. Busuttil, Jerzy W. Kupiec-Weglinski
Farin Amersi, … , Ronald W. Busuttil, Jerzy W. Kupiec-Weglinski
Published December 1, 1999
Citation Information: J Clin Invest. 1999;104(11):1631-1639. https://doi.org/10.1172/JCI7903.
View: Text | PDF
Article

Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury

  • Text
  • PDF
Abstract

We examined the effects of upregulation of heme oxygenase-1 (HO-1) in steatotic rat liver models of ex vivo cold ischemia/reperfusion (I/R) injury. In the model of ischemia/isolated perfusion, treatment of genetically obese Zucker rats with the HO-1 inducer cobalt protoporphyrin (CoPP) or with adenoviral HO-1 (Ad-HO-1) significantly improved portal venous blood flow, increased bile production, and decreased hepatocyte injury. Unlike in untreated rats or those pretreated with the HO-1 inhibitor zinc protoporphyrin (ZnPP), upregulation of HO-1 by Western blots correlated with amelioration of histologic features of I/R injury. Adjunctive infusion of ZnPP abrogated the beneficial effects of Ad-HO-1 gene transfer, documenting the direct involvement of HO-1 in protection against I/R injury. Following cold ischemia/isotransplantation, HO-1 overexpression extended animal survival from 40% in untreated controls to about 80% after CoPP or Ad-HO-1 therapy. This effect correlated with preserved hepatic architecture, improved liver function, and depressed infiltration by T cells and macrophages. Hence, CoPP- or gene therapy–induced HO-1 prevented I/R injury in steatotic rat livers. These findings provide the rationale for refined new treatments that should increase the supply of usable donor livers and ultimately improve the overall success of liver transplantation.

Authors

Farin Amersi, Roland Buelow, Hirohisa Kato, Bibo Ke, Ana J. Coito, Xiu-Da Shen, Delai Zhao, Joseph Zaky, Judy Melinek, Charles R. Lassman, Jay K. Kolls, J. Alam, Thomas Ritter, Hans-Dieter Volk, Douglas G. Farmer, Rafik M. Ghobrial, Ronald W. Busuttil, Jerzy W. Kupiec-Weglinski

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Effects of I/R injury on sGOT release from fatty livers cold stored for ...
Effects of I/R injury on sGOT release from fatty livers cold stored for 6 hours followed by 2 hours of ex vivo perfusion. Levels (IU/L) were measured in blood samples taken at 30-minute intervals during the perfusion. Levels of sGOT were significantly lower at 30, 60, and 90 minutes during the perfusion of livers pretreated with CoPP or Ad-HO-1 as compared with untreated controls or those pretreated with ZnPP or Ad-βGal. These data represent the mean ± SE of 4–10 measurements for each group. *P < 0.05 versus untreated/ZnPP-treated control.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts